| Neuroprotection by caffeine in the MPTP model of parkinson’s disease and its dependence on adenosine A2A receptors K Xu, DG Di Luca, M Orrú, Y Xu, JF Chen, MA Schwarzschild Neuroscience 322, 129-137, 2016 | 78 | 2016 |
| Gender disparities in deep brain stimulation for Parkinson's disease DS Shpiner, DG Di Luca, I Cajigas, JS Diaz, J Margolesky, H Moore, ... Neuromodulation: Technology at the Neural Interface 22 (4), 484-488, 2019 | 36 | 2019 |
| Central and peripheral fat body mass have a protective effect on osteopenia or osteoporosis in adults and elderly? P Freitas, ML Garcia Rosa, AM Gomes, V Wahrlich, DG Di Luca, ... Osteoporosis international 27, 1659-1663, 2016 | 30 | 2016 |
| Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease DG Di Luca, M Feldman, S Jimsheleishvili, J Margolesky, JG Cordeiro, ... Parkinsonism & related disorders 77, 13-17, 2020 | 18 | 2020 |
| Minority enrollment in Parkinson’s disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms DG Di Luca, JA Sambursky, J Margolesky, JG Cordeiro, A Diaz, ... Journal of Parkinson's disease 10 (4), 1709-1716, 2020 | 18 | 2020 |
| Safety of noncontrast imaging–guided deep brain stimulation electrode placement in parkinson disease JG Cordeiro, A Diaz, JK Davis, DG Di Luca, G Farooq, CC Luca, JR Jagid World neurosurgery 134, e1008-e1014, 2020 | 12 | 2020 |
| Newly approved and investigational drugs for motor symptom control in Parkinson's disease DG Di Luca, NGD Reyes, SH Fox Drugs 82 (10), 1027-1053, 2022 | 11 | 2022 |
| Superposition of leprosy and other neglected tropical diseases in the state of Rio de Janeiro: a case series report DG Di Luca, PJS De Andrade, AM Sales, VM De Menezes, ... Leprosy review 84 (4), 302-307, 2013 | 8 | 2013 |
| Racial and ethnic differences in health-related quality of life for individuals with Parkinson disease across centers of excellence DG Di Luca, S Luo, H Liu, M Cohn, TL Davis, A Ramirez-Zamora, ... Neurology 100 (21), e2170-e2181, 2023 | 7 | 2023 |
| Individualized anatomy-based targeting for VIM-cZI DBS in essential tremor A Diaz, I Cajigas, JG Cordeiro, A Mahavadi, S Sur, DG Di Luca, ... World neurosurgery 140, e225-e233, 2020 | 7 | 2020 |
| Evaluation of knowledge of the term" nephrology" in a population sample DG Di Luca, DCL Oliveira, LER Guimarães, GC Tamiasso, LBZ Goulart, ... Brazilian Journal of Nephrology 35, 107-111, 2013 | 7 | 2013 |
| CVT-301 for the treatment of Parkinson’s disease DS Shpiner, S Bette, DG Di Luca, J Margolesky Expert review of neurotherapeutics 19 (7), 603-611, 2019 | 6 | 2019 |
| Paroxysmal sympathetic hyperactivity with dystonia following non-traumatic bilateral thalamic and cerebellar hemorrhage DG Di Luca, NJ Mohney, M Kottapally Neurocritical care 30, 688-689, 2019 | 6 | 2019 |
| MPTP Parkinsonism and Implications for Understanding Parkinson's Disease S AlShimemeri, DG Di Luca, SH Fox Movement Disorders Clinical Practice 9 (1), 42, 2022 | 5 | 2022 |
| Clinical and economic outcomes associated with dysphagia in hospitalized patients with Parkinson’s disease DG Di Luca, EW McArthur, A Willis, R Martino, C Marras Journal of Parkinson's Disease 11 (4), 1965-1971, 2021 | 5 | 2021 |
| Severe tooth loss secondary to orofacial dyskinesias in anti-NMDA receptor encephalitis DG Di Luca, JH Margolesky BMJ Case Reports CP 12 (3), e228380, 2019 | 4 | 2019 |
| Enrollment of participants from marginalized racial and ethnic groups: a comparative assessment of the STEADY-PD III and SURE-PD3 trials DG Di Luca, EA Macklin, K Hodgeman, G Lopez, L Pothier, KF Callahan, ... Neurology: Clinical Practice 13 (1), e200113, 2023 | 3 | 2023 |
| Dream Enactment Behavior Disorder Associated with Pallido‐Nigro‐Luysian Degeneration and Tau Proteinopathy DG Di Luca, EJ Slow, I Martinez‐Valbuena, AE Lang, GG Kovacs Movement Disorders Clinical Practice 8 (4), 594-599, 2021 | 3 | 2021 |
| Palliative Care in Parkinson Disease—Is It Beneficial for All? DG Di Luca, C Singer, JH Margolesky JAMA neurology 77 (11), 1450-1450, 2020 | 3 | 2020 |
| Minority enrollment in Parkinson’s Disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms.(2104) DG Di Luca, J Sambursky, A Diaz, JG Cordeiro, D Shpiner, J Margolesky, ... Neurology 94 (15 Supplement), 2020 | 3 | 2020 |
